Tetracore, Inc.
Biotechnology ResearchMaryland, United States51-200 Employees
Tetracore, Inc. is a biotechnology research and development firm that creates detection tools for infectious diseases, biological warfare threats, and related biomarkers. It emphasizes antibody-based and nucleic acid–based detection reagents and technologies, offering rapid, highly specific test kits and reagents for identifying BW agents and toxins, including the first FDA-cleared kit for identifying B. anthracis from colonies. The company also develops real-time PCR tests for animal pathogens, broadening its diagnostic capabilities. Based in Rockville, Maryland, the company performs contracted work for the U.S. government to develop real-time PCR diagnostics for BW agents and related nucleic acid technologies. Founding scientists bring experience from leadership roles in the Joint Program Office for Bio-defense, the Department of Defense, the FBI, and the DOE, anchoring the firm in biodefense diagnostics. In 2023, it expanded its veterinary diagnostics footprint through a USDA APHIS partnership to supply PCR kits for African Swine Fever and Foot-and-Mouth Disease, and launched USDA-licensed real-time PCR tests for ASF in swine.